← Back to Patent Explorer
US6015815A Expired / Lapsed US ⏱️ 0.0 years remaining

Tetrazole-containing rapamycin analogs with shortened half-lives

Assignee: Abbott Laboratories
•
Filing: 1998-09-24
•
Granted: 2000-01-18
•
Expires: 2018-09-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound having the formula ##STR1## or a pharmaceutically acceptible salt or prodrug thereof, is an immunomodulatory agent and is usefull in the treatment of restenosis and immune and autoimmune diseases. Also disclosed are cancer-, fungal growth-, restenosis-, post-transplant tissue rejection- and immune- and autoimmune disease-inhibiting compositions and a method of inhibiting cancer, fungal growth, restenosois, post-transplant tissue rejection, and immune and autoimmune disease in a mammal.

Inventors

  • 👤 Karl W. Mollison

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 00:41
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 14 words
A compound having the formula ##STR7## or a pharmaceutically acceptible salt or prodrug thereof.
Claim 2
Dependent Claim 14 words
A compound having the formula ##STR7## or a pharmaceutically acceptible salt or prodrug thereof.
Claim 3
Dependent Claim 9 words
A compound according to claim 1 of formula ##STR8##
Claim 4
Dependent Claim 8 words
A compound according to claim 1 of formula

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-01-17 2003-07-19 2004-01-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-01-17 2007-07-19 2008-01-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-01-17 2011-07-19 2012-01-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag